175 related articles for article (PubMed ID: 26420860)
1. The Metabolic Regulator Histone Deacetylase 9 Contributes to Glucose Homeostasis Abnormality Induced by Hepatitis C Virus Infection.
Chen J; Wang N; Dong M; Guo M; Zhao Y; Zhuo Z; Zhang C; Chi X; Pan Y; Jiang J; Tang H; Niu J; Yang D; Li Z; Han X; Wang Q; Chen X
Diabetes; 2015 Dec; 64(12):4088-98. PubMed ID: 26420860
[TBL] [Abstract][Full Text] [Related]
2. Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis.
Chen J; Zhang Z; Wang N; Guo M; Chi X; Pan Y; Jiang J; Niu J; Ksimu S; Li JZ; Chen X; Wang Q
Sci Rep; 2017 Jul; 7(1):6102. PubMed ID: 28733598
[TBL] [Abstract][Full Text] [Related]
3. The metabolic regulator small heterodimer partner contributes to the glucose and lipid homeostasis abnormalities induced by hepatitis C virus infection.
Chen J; Zhou Y; Zhuang Y; Qin T; Guo M; Jiang J; Niu J; Li JZ; Chen X; Wang Q
Metabolism; 2019 Nov; 100():153954. PubMed ID: 31400386
[TBL] [Abstract][Full Text] [Related]
4. The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.
Shlomai A; Rechtman MM; Burdelova EO; Zilberberg A; Hoffman S; Solar I; Fishman S; Halpern Z; Sklan EH
J Hepatol; 2012 Oct; 57(4):867-73. PubMed ID: 22732512
[TBL] [Abstract][Full Text] [Related]
5. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver.
Oiso H; Furukawa N; Suefuji M; Shimoda S; Ito A; Furumai R; Nakagawa J; Yoshida M; Nishino N; Araki E
Biochem Biophys Res Commun; 2011 Jan; 404(1):166-72. PubMed ID: 21108932
[TBL] [Abstract][Full Text] [Related]
6. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.
Bernsmeier C; Calabrese D; Heim MH; Duong HT
J Viral Hepat; 2014 Jan; 21(1):9-18. PubMed ID: 24329853
[TBL] [Abstract][Full Text] [Related]
8. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.
Mihaylova MM; Vasquez DS; Ravnskjaer K; Denechaud PD; Yu RT; Alvarez JG; Downes M; Evans RM; Montminy M; Shaw RJ
Cell; 2011 May; 145(4):607-21. PubMed ID: 21565617
[TBL] [Abstract][Full Text] [Related]
9. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
10. Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice.
Ziegler N; Raichur S; Brunner B; Hemmann U; Stolte M; Schwahn U; Prochnow HP; Metz-Weidmann C; Tennagels N; Margerie D; Wohlfart P; Bielohuby M
Front Endocrinol (Lausanne); 2020; 11():598. PubMed ID: 32982982
[TBL] [Abstract][Full Text] [Related]
11. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
[TBL] [Abstract][Full Text] [Related]
12. Identifying targets for the restoration and reactivation of BRM.
Kahali B; Gramling SJ; Marquez SB; Thompson K; Lu L; Reisman D
Oncogene; 2014 Jan; 33(5):653-64. PubMed ID: 23524580
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.
Zhang P; Tu B; Wang H; Cao Z; Tang M; Zhang C; Gu B; Li Z; Wang L; Yang Y; Zhao Y; Wang H; Luo J; Deng CX; Gao B; Roeder RG; Zhu WG
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10684-9. PubMed ID: 25009184
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.
Deng L; Shoji I; Ogawa W; Kaneda S; Soga T; Jiang DP; Ide YH; Hotta H
J Virol; 2011 Sep; 85(17):8556-68. PubMed ID: 21697492
[TBL] [Abstract][Full Text] [Related]
16. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
17. FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.
Singh BK; Sinha RA; Zhou J; Xie SY; You SH; Gauthier K; Yen PM
J Biol Chem; 2013 Oct; 288(42):30365-30372. PubMed ID: 23995837
[TBL] [Abstract][Full Text] [Related]
18. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
Kurano M; Hara M; Satoh H; Tsukamoto K
Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
[TBL] [Abstract][Full Text] [Related]
19. Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis.
Zou Y; Gong N; Cui Y; Wang X; Cui A; Chen Q; Jiao T; Dong X; Yang H; Zhang S; Fang F; Chang Y
J Biol Chem; 2015 Dec; 290(51):30607-15. PubMed ID: 26504089
[TBL] [Abstract][Full Text] [Related]
20. Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
Valenti L; Rametta R; Dongiovanni P; Maggioni M; Fracanzani AL; Zappa M; Lattuada E; Roviaro G; Fargion S
Diabetes; 2008 May; 57(5):1355-62. PubMed ID: 18316359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]